Doximity Inc. (DOCS)
Doximity Inc. (DOCS) Stock Price, Analysis & Data
| Bid | 25.33 |
| Market Cap | 4.61B |
| Revenue (ttm) | 655.57M |
| Net Income (ttm) | 167.05M |
| Beta | 1.21 |
| EPS (ttm) | 0.84 |
| PE Ratio (ttm) | 30.77 |
| Forward PE | 16.67 |
| P/B (ttm) | 5.07 |
| P/S (ttm) | 7.02 |
| Earnings Date | Nov 5, 2026 |
| Ask | 25.34 |
| Volume | 1,354,535 |
| Avg. Volume (20D) | 4,889,179 |
| Open | 24.95 |
| Previous Close | 24.94 |
| Day's Range | 24.81 - 25.49 |
| 52-Week Range | 17.15 - 76.51 |
| Analyst | Hold |
| Price Target | 28 (10.28%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About DOCS
Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored ...
Financial Performance
In 2026, Doximity's revenue was 644.86M, an increase of 13.05% compared to the previous year's 570.4M. Earnings were 196.05M, a decrease of -12.16%.
Financial StatementsAnalyst Forecast
According to 18 analyst ratings, the average rating for DOCS stock is "Hold". The 12-month stock price forecast is 28, which is upside of 10.28% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
17 hours ago · Simply Wall St.
Doximity (DOCS) Could Be 26% Below Fair Value On Strong Earnings GuidanceDoximity (DOCS) is back in focus after its latest quarterly report showed higher sales, raised full year revenue guidance, and continued margin pressure tied to heavier spending on AI tools. See our l...
